| Date Filed | Type | Description |
| 06/09/2023 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
3
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 3 on Acrivon Therapeutics, Inc. |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
4
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 2,800 shares
@ $91.39, valued at
$255.9k
Sold 6,400 shares
@ $92.23, valued at
$590.3k
Sold 2,800 shares
@ $93.18, valued at
$260.9k
Exercised 12,000 options to buy
@ $17.75, valued at
$213k
|
|
| 08/05/2020 |
4
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Exercised 12,000 shares
@ $17.75, valued at
$213k
Sold 6,552 shares
@ $86.2528, valued at
$565.1k
Sold 5,448 shares
@ $87.333, valued at
$475.8k
Exercised 12,000 options to buy
@ $17.75, valued at
$213k
|
|
| 06/08/2020 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.74, valued at
$56.1k
|
|
| 03/12/2020 |
4
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 35,000 options to buy
@ $44.67, valued at
$1.6M
Granted 8,500 restricted stock units
@ $0 |
|
| 12/05/2019 |
4
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 05/08/2019 |
3
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 3 on Milestone Pharmaceuticals Inc. |
| 03/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2018 |
4
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 20,760 options to buy
@ $59.31, valued at
$1.2M
|
|
| 03/09/2018 |
4
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 25,000 options to buy
@ $51.49, valued at
$1.3M
|
|
| 11/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2017 |
3
| TOMSICEK MICHAEL JOHN (CFO) has filed a Form 3 on CRISPR Therapeutics AG |
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/02/2013 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Acquired 74 shares
@ $63.55, valued at
$4.7k
|
|
| 09/05/2013 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Sold 400 shares
@ $64.08, valued at
$25.6k
|
|
| 04/16/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2013 |
3
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 3 on CUBIST PHARMACEUTICALS INC |